Advanced searches left 3/3

Cardiogenic - DOAJ

Summarized by Plex Scholar
Last Updated: 10 September 2022

* If you want to update the article please login/register

Mechanical Circulatory Support Devices for the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction—A Review

Rapid myocardial infarction complicating acute myocardial infarction is a difficult medical condition associated with dismal prognosis. This article explores the most common difficulties associated with this procedure and the latest developments in the area of cardiogenic shock following acute myocardial infarction.

Source link: https://doi.org/10.3390/jcm11175241


Inodilators May Improve the In-Hospital Mortality of Patients with Cardiogenic Shock Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation

Although inodilators are widely used for cardiogenic shock, the efficacy of inodilators for patients with CS undergoing veno-arterial extracorporeal membrane oxygenation is uncertain. Using the RESCUE registry, we investigated the effects of inodilators on clinical outcomes. After 1:1 propensity score matching, we selected 191 matched pairs to adjust for baseline clinical characteristics. Inodilators can help with clinical outcomes in patients with CS undergoing VA-ECMO.

Source link: https://doi.org/10.3390/jcm11174958


Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure–Related Cardiogenic Shock

Patients with decompensated heart failure are often seen with moderate to severe functional mitral regurgitation, which is associated with worse outcomes. When used in combination with preexisting FMR, there is no information about the effect of the Impella device on hemodynamic response. FMR ranges from moderate to severe FMR, 33% had moderate-to-moderate/moderate FMR, 38 percent had moderate-to-moderate FMR, and 29 percent had trace/mild FMR on pre-Impella transthoracic echocardiogram. In 3 patients, one had severe, one had moderate, and another had mild FMR pre-Impella. Impella did not seem to significantly reduce FMR severity in a retrospective cohort of patients admitted with HF-CS who underwent Impella 5. 5 implant for hemodynamic assistance, but not appear to dramatically reduce FMR severity. Impella 5. 5 may have sufficient hemodynamic assistance in the presence of elevated severity FMR in carefully selected patients, especially those with isolated left ventricular dysfunction.

Source link: https://doi.org/10.1016/j.shj.2022.100072


Intensive Care Management of the Cardiogenic Shock Patient

A thorough and systematic review of all organ systems is required to ensure the safety and convenience of patients with cardiogenic shock, as well as avoiding the complications of critical illness. These most critically ill patients' evaluation and care are therefore in need of extensive knowledge and expertise relating to cardiac intensive care, which extends well beyond traditional intensive care or cardiology practice.

Source link: https://doi.org/10.15420/usc.2021.23


Pulmonary Artery Catheter Monitoring in Patients with Cardiogenic Shock: Time for a Reappraisal?

The use of the Swan-Ganz catheter may have a pivotal role in several phases of cardiovascular shock therapy, from diagnosis and haemodynamic characterization to treatment selection, titration, and weaning. This paper provides a historical background on the use of the Swan-Ganz catheter in the intensive care unit as well as an analysis of the available evidence in terms of potential prognostic implications in this setting.

Source link: https://doi.org/10.15420/cfr.2021.32


Advocacy and Legislation for Regionalization Practices in the Treatment of Cardiogenic Shock: The Time Is Now

Based on studies and historical experiences with similar life-threatening disorders, a national system in the United States of regionalized, structured care for patients with cardiogenic shock has the potential to enhance outcomes and save lives.

Source link: https://doi.org/10.15420/usc.2021.14


Hemodynamic-based Assessment and Management of Cardiogenic Shock

Cardiogenic shock remains a deadly disease threat to patients, caregivers, and communities around the world. We review systemic hemodynamic-based transitions in which diverse clinical entities share the common pathway of early identification and swift transitions in an adaptive longitudinal situational knowledge model of care that influences specific management considerations. Based on the scalable heterogeneity in healthcare delivery of patients experiencing CS, we discuss how healthcare clinics can adapt to a cellular level to healthcare systems.

Source link: https://doi.org/10.15420/usc.2021.12


Cardiogenic Shock Management and Research: Past, Present, and Future Outlook

Although major strides have been made in the pathophysiological investigation, diagnosis, and management of cardiogenic shock, morbidity, and mortality among patients with the condition remain high. Acute MI is the most common cause of CS; therefore, the majority of new research focuses on MI-associated CS. However, there are several other phenotypes of patients with acute heart disease.

Source link: https://doi.org/10.15420/usc.2021.25


Extracorporeal Life Support for Cardiac Arrest and Cardiogenic Shock

The purpose of this review is to summarize current evidence in the context of four main areas that concern VA-ECMO services: the principles of patient selection; basic hemodynamic and scientific principles underpinning VA-ECMO therapy; condoindications to VA-ECMO therapy; and common problems and acute care issues that are encountered in the setting of VA-ECMO therapy.

Source link: https://doi.org/10.15420/usc.2021.13


Cardiogenic Shock: Protocols, Teams, Centers, and Networks

The mortality of cardiogenic shock remains alarmingly high. A volume-outcome relationship exists in CS, as with several other acute cardiovascular diseases, as well as the emergence of u2018shock hubs as an established network with an interest in improving CS outcomes by a hub-and-spoke u2019 strategy, providing another avenue for providing enhanced CS services as widely and ethically as possible.

Source link: https://doi.org/10.15420/usc.2021.10

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions